Let's talk Controversies in Modern Eye Care: what to expect

Video

Hear from Robert Maloney, MD, about what to expect—and what he's excited about—for this year's 2023 Controversies in Modern Eye Care meeting held this April in Los Angeles, California.

Robert Maloney, MD, of the Maloney-Shamie Vision Institute and one of the co-chairs of the 17th annual Controversies in Modern Eye Care meeting, caught up with Optometry Times®' editor Kassi Jackson to share what attendees can expect from the April meeting in Los Angeles.

Editor's note: This transcript has been edited for clarity.

Jackson:

Hi everyone, I'm Kassi Jackson with Optometry Times, and I'm sitting down with Dr. Robert Maloney, who's presenting at the 17th annual Controversies in Modern Eye Care meeting in Los Angeles, California, this year in April 2023. Welcome Dr. Maloney, thank you for taking the time to talk with us.

Maloney:

Yes, it's great to hear you .

Jackson:

Why should practitioners be excited about this year's controversies and modern eye care meeting?

Maloney:

So Controversies meeting is, we think, a wonderful meeting because it focuses on areas of controversy rather than kind of the didactic stuff that's so often part of presentations. What are the difficult questions? What are the hard management issues? We try and stick to those questions, as opposed to giving our attendees lectures they may hear in school. And so I think that really sets us apart. It's also a fun meeting. It's very social, we have enough breaks that people can catch up with their friends—a lot of times see old colleagues from optometry school who they haven't seen for a while. And so it makes it a fun meeting and one that's educational.

Jackson:

That's awesome. And what are you most excited to share at this meeting?

Maloney:

Well, what I'm most excited about is seeing old friends. And this is the one meeting a year where I get to see a number of my physician colleagues in the community to catch up to find out how their practices are going, how their families are going [and] to share a cup of coffee. And for me, that's the part I enjoy the most.

Jackson:

That's wonderful. So what can clinicians expect from this year's meeting?

Maloney:

Clinicians can expect to have a high-level educational experience that's oriented to people who are smart, thoughtful, knowledgeable about their field, but want to take the practice to the next level.

Jackson:

And what sets the Controversies meeting apart from other conferences?

Maloney:

The Controversies meeting, I think is really set apart by its focus on areas of controversy, rather than simply reviewing the material one learns in school or in residency. And I think that makes it more interesting meeting and very useful for day-to-day practice.

Jackson:

And is there anything else you'd like to mention that we haven't touched on?

Maloney:

Dammit, you hit it all.

Jackson:

Wonderful. Well, Dr. Maloney, thank you so much for your time today.

Visit here to register for the conference.

Recent Videos
EnVision Summit Co-chairs Sherrol Reynolds, OD, FAAO; Katie Rachon, OD, FAAO, Dipl ABO; Jessica Steen, OD, FAAO, Dipl ABO; and Cecelia Koetting, OD, FAAO, Dipl ABO; express excitement for the upcoming conference and why optometrists should attend.
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
© 2024 MJH Life Sciences

All rights reserved.